Principal at Negev Capital since 2022. Dr. Adamsky has a long-demonstrated track record in pharmaceutical R&D and business development. He served as a VP Operations and Technology at Levco Pharmaceuticals Ltd, CEO and VP Operations at Regenera Pharma LTD, co-founder, Director and co-CEO at Targia Pharmaceuticals, Co-founder and Director of Celleska Pty, Australian Cell & Gene Therapy Incubator. Dr. Adamsky has also held positions at Compugen and the Weizmann Institute of Science. Dr. Adamsky holds his Ph.D. from the Weizmann Institute of Science.